AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cellebrite DI Ltd.

$11.23 -$6.61 (-37.05%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$11.32
Day Range
$11.05$11.5
Year Range
$9.58$19.98
Market Cap
2.8B
AVG Volume
2.69M
Trailing/Forward PE
47.71/29.95
PEG ratio
1.33
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Revenue (USD)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2131.14M
26 Q1128.3M
25 Q4128.82M
25 Q3126.03M
25 Q2113.28M
25 Q1107.55M
24 Q4109.05M
24 Q3106.86M
24 Q295.71M
24 Q189.58M
Net Income (USD)
-300M-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q26.37M
26 Q110.94M
25 Q421.26M
25 Q320.19M
25 Q219.48M
25 Q117.4M
24 Q419.27M
24 Q3-207.09M
24 Q2-23.81M
24 Q1-71.37M
Operating Income (USD)
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q27.63M
26 Q19.12M
25 Q420.8M
25 Q318.99M
25 Q214.42M
25 Q112.27M
24 Q415.73M
24 Q319.45M
24 Q212.49M
24 Q19.25M
EBITDA (USD)
-400M-300M-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q216.54M
26 Q120.64M
25 Q449.47M
25 Q326.99M
25 Q230.52M
25 Q121.96M
24 Q4-314.4M
24 Q322.07M
24 Q215.06M
24 Q111.93M
Cash Flows (USD)
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q214.52M
26 Q116.84M
25 Q478.27M
25 Q329.95M
25 Q228.98M
25 Q118.54M
24 Q461.65M
24 Q339.83M
24 Q212.16M
24 Q17.92M
EPS (USD)
-1-0.500.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.03
26 Q10.04
25 Q40.08
25 Q30.08
25 Q20.08
25 Q10.07
24 Q40.08
24 Q3-0.99
24 Q2-0.12
24 Q1-0.36
Expenses (USD)
050M100M150MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2101.37M
26 Q199.8M
25 Q492.28M
25 Q390.05M
25 Q284.79M
25 Q180.13M
24 Q480.02M
24 Q373.79M
24 Q269.32M
24 Q169.19M
Cash & Debt (USD)
0200M400M600MCashShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2442.53M
26 Q1429.07M
25 Q4437.05M
25 Q3525.71M
25 Q2472.18M
25 Q1409.49M
24 Q4447.22M
24 Q3370.76M
24 Q2305.31M
24 Q1276.55M
Debt ratios
-5051024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Debt ratios by quarter
PeriodDebt ratios
26 Q2-3.69
26 Q1-3.18
25 Q4-3.21
25 Q32.15
25 Q21.88
25 Q11.56
24 Q41.64
24 Q38.54
24 Q26.09
24 Q14.7
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Margins by quarter
PeriodMargins
26 Q280.78%
26 Q182.53%
25 Q484.71%
25 Q383.88%
25 Q284.39%
25 Q183.74%
24 Q483.84%
24 Q385.55%
24 Q283.01%
24 Q185.19%
Return on Capital
-100%0%100%200%300%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Return on Capital by quarter
PeriodReturn on Capital
26 Q21.18%
26 Q12.14%
25 Q44.39%
25 Q34.51%
25 Q24.77%
25 Q14.79%
24 Q45.73%
24 Q3-69.42%
24 Q259.29%
24 Q1267.25%
Shares Outstanding
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2247.62M
26 Q1246.47M
25 Q4251.5M
25 Q3249.72M
25 Q2240.36M
25 Q1248.57M
24 Q4233.25M
24 Q3208.71M
24 Q2198.95M
24 Q1196.82M
Book Value Per Share (USD)
-1012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q22.17
26 Q12.07
25 Q41.93
25 Q31.79
25 Q21.7
25 Q11.46
24 Q41.44
24 Q31.43
24 Q2-0.2
24 Q1-0.14
Total Assets (USD)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLBT Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2994.31M
26 Q1952.29M
25 Q4938.85M
25 Q3834.32M
25 Q2787.42M
25 Q1709.89M
24 Q4690.57M
24 Q3629.25M
24 Q2556.58M
24 Q1529.14M
Employee Count
05001K1.5K20212022202320242025
CLBT Employee Count by quarter
PeriodEmployee Count
20251.28K
20241.17K
20231.01K
20221K
2021900
PE Ratio
020406080med 42.29Sep 22Dec 22Apr 23Jul 23Feb 26May 26Sep 26
CLBT PE Ratio by quarter
PeriodPE Ratio
Sep 2647.32
Sep 2648.25
Aug 2650.53
Aug 2646.57
Aug 2646.95
Aug 2654.91
Jul 2650.59
Jul 2648.77
Jul 2652.95
Jul 2654.67
Jul 2653.67
Jun 2647.19
Jun 2644
Jun 2644.04
Jun 2647.36
May 2647.3
May 2642.32
May 2641.68
May 2643.73
May 2642.87
Apr 2640.78
Apr 2642.32
Apr 2635.42
Apr 2644.95
Mar 2641.58
Mar 2645.82
Mar 2646.37
Mar 2649.13
Feb 2642.83
Feb 2642.26
Feb 2647.01
Feb 2646.36
Jan 2648.12
Jan 2651.92
Jan 2655.61
Jan 2660.39
Jan 2658.36
Dec 2560.23
Dec 2562.84
Dec 2561.57
Dec 2559.8
Nov 2555.16
Nov 2555.22
Nov 2560.36
Aug 2355.61
Jul 2357.27
Jul 2357.27
Jul 2352.53
Jul 2351.62
Jun 2354.18
Jun 2347.71
Jun 2348.39
Jun 2346.28
Jun 2342.97
May 2343.65
May 2341.99
May 2341.16
May 238.27
Apr 238.28
Apr 238.85
Apr 238.79
Apr 238.57
Mar 239.32
Mar 238.97
Mar 238.85
Mar 238.99
Mar 239.37
Feb 238.83
Feb 238.8
Feb 235.93
Feb 236.46
Jan 236.17
Jan 235.35
Jan 235.12
Jan 235.19
Dec 225.08
Dec 224.87
Dec 225.06
Dec 225
Dec 225.21
Nov 225.4
Nov 225.38
Nov 226.33
Nov 226.23
Oct 226.3
Oct 226.19
Oct 225.55
Oct 225.61
Sep 225.09
Sep 225.59
Sep 225.68
Sep 225.94
Sep 226.19
Aug 226.24
Aug 226.36
Aug 226.94
Aug 229.07
Jul 228.04
Jul 228.8
Jul 228.34
Free Cash Flow Yield
1%2%3%4%5%6%med 3.39%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CLBT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 265.02%
Sep 264.92%
Aug 264.7%
Aug 265.1%
Aug 265.06%
Aug 263.9%
Jul 264.24%
Jul 264.4%
Jul 264.05%
Jul 263.92%
Jul 263.99%
Jun 264.54%
Jun 264.87%
Jun 264.87%
Jun 264.53%
May 264.2%
May 264.7%
May 264.77%
May 264.55%
May 264.64%
Apr 264.88%
Apr 264.7%
Apr 265.61%
Apr 264.42%
Mar 264.78%
Mar 264.34%
Mar 264.29%
Mar 264.05%
Feb 264.64%
Feb 264.71%
Feb 264.23%
Feb 263.93%
Jan 263.79%
Jan 263.51%
Jan 263.28%
Jan 263.02%
Jan 263.12%
Dec 253.03%
Dec 252.9%
Dec 252.96%
Dec 253.05%
Nov 253.3%
Nov 253.3%
Nov 253.02%
Nov 254.03%
Oct 253.63%
Oct 253.32%
Oct 253.41%
Oct 253.25%
Oct 253.33%
Sep 253.33%
Sep 253.52%
Sep 253.69%
Sep 253.73%
Aug 253.78%
Aug 253.85%
Aug 253.97%
Aug 253.92%
Aug 253.88%
Jul 253.71%
Jul 253.7%
Jul 253.64%
Jul 253.44%
Jun 253.36%
Jun 253.44%
Jun 253.37%
Jun 253.22%
May 253.19%
May 253.09%
May 253.05%
May 252.63%
May 252.59%
Apr 252.65%
Apr 252.76%
Apr 252.71%
Apr 252.94%
Mar 252.68%
Mar 252.71%
Mar 252.59%
Mar 252.69%
Feb 252.55%
Feb 252.48%
Feb 252.31%
Feb 251.86%
Jan 251.97%
Jan 252%
Jan 252.08%
Jan 252.19%
Jan 252.14%
Dec 242.13%
Dec 242.1%
Dec 242.38%
Dec 242.22%
Nov 242.35%
Nov 242.4%
Nov 242.67%
Nov 242.54%
Nov 242.36%
Oct 242.39%
Oct 242.41%
Price to Sales
57.51012.515med 9.33Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CLBT Price to Sales by quarter
PeriodPrice to Sales
Sep 265.41
Sep 265.51
Aug 265.77
Aug 265.32
Aug 265.36
Aug 267.95
Jul 267.32
Jul 267.06
Jul 267.67
Jul 267.91
Jul 267.77
Jun 266.83
Jun 266.37
Jun 266.37
Jun 266.86
May 267.79
May 266.97
May 266.86
May 267.2
May 267.06
Apr 266.71
Apr 266.97
Apr 265.83
Apr 267.4
Mar 266.85
Mar 267.54
Mar 267.63
Mar 268.09
Feb 267.05
Feb 266.96
Feb 267.74
Feb 267.76
Jan 268.06
Jan 268.69
Jan 269.31
Jan 2610.11
Jan 269.77
Dec 2510.08
Dec 2510.52
Dec 2510.31
Dec 2510.01
Nov 259.24
Nov 259.25
Nov 2510.11
Nov 258.48
Oct 259.39
Oct 2510.27
Oct 2510.01
Oct 2510.51
Oct 2510.25
Sep 2510.25
Sep 259.69
Sep 259.25
Sep 259.14
Aug 259.03
Aug 258.87
Aug 258.59
Aug 258.05
Aug 258.12
Jul 258.49
Jul 258.53
Jul 258.65
Jul 259.16
Jun 259.39
Jun 259.17
Jun 259.36
Jun 259.8
May 259.89
May 2510.21
May 2510.32
May 2511.53
May 2511.71
Apr 2511.42
Apr 2510.99
Apr 2511.17
Apr 2510.3
Mar 2511.31
Mar 2511.18
Mar 259.89
Mar 259.52
Feb 2510.06
Feb 2510.36
Feb 2511.11
Feb 2513.77
Jan 2513.03
Jan 2512.84
Jan 2512.34
Jan 2511.69
Jan 2511.98
Dec 2412.03
Dec 2412.2
Dec 2410.77
Dec 2411.57
Nov 2410.93
Nov 2410.69
Nov 249.59
Nov 2410.08
Nov 2410.17
Oct 2410.04
Oct 249.96
EV/EBITDA
0102030med 7.54Jan 23May 23Aug 23Dec 23Feb 26May 26Sep 26
CLBT EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2620.78
Sep 2621.26
Aug 2622.44
Aug 2620.39
Aug 2620.58
Aug 2627.74
Jul 2625.3
Jul 2624.28
Jul 2626.64
Jul 2627.6
Jul 2627.04
Jun 2623.39
Jun 2621.59
Jun 2621.61
Jun 2623.49
May 2625.52
May 2622.49
May 2622.1
May 2623.35
May 2622.83
Apr 2621.56
Apr 2622.49
Apr 2618.3
Apr 2624.09
Mar 2622.05
Mar 2624.62
Mar 2624.95
Mar 2626.63
Feb 2622.81
Feb 2622.46
Feb 2625.34
Mar 2412.43
Mar 2412.31
Mar 2413.33
Feb 2412.63
Feb 2412.24
Feb 249.86
Feb 249.59
Jan 249.64
Jan 248.77
Jan 248.35
Jan 248.4
Dec 238.92
Dec 239.05
Dec 238.41
Dec 238.79
Dec 238.63
Nov 238.13
Nov 237.61
Nov 236.89
Nov 236.8
Oct 235.87
Oct 236.43
Oct 236.51
Oct 237.14
Sep 237.21
Sep 236.98
Sep 236.92
Sep 237.47
Sep 237.81
Aug 237.26
Aug 237.16
Aug 237.27
Aug 236.05
Jul 236.26
Jul 236.26
Jul 235.67
Jul 235.55
Jun 235.87
Jun 235.06
Jun 235.14
Jun 234.88
Jun 234.46
May 234.55
May 234.34
May 234.23
May 233.32
Apr 233.32
Apr 233.6
Apr 233.57
Apr 233.46
Mar 233.83
Mar 233.66
Mar 233.6
Mar 233.66
Mar 233.85
Feb 233.59
Feb 233.58
Feb 234.33
Feb 234.78
Jan 234.53
Jan 233.83
Jan 233.63
Jan 233.69
Dec 223.6
Dec 223.42
Dec 223.58
Dec 223.53
Dec 223.71
Nov 223.88
Price/Operating Cashflow
1020304050med 27.28Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CLBT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2618.18
Sep 2618.53
Aug 2619.41
Aug 2617.89
Aug 2618.03
Aug 2623.49
Jul 2621.64
Jul 2620.87
Jul 2622.66
Jul 2623.39
Jul 2622.96
Jun 2620.19
Jun 2618.83
Jun 2618.84
Jun 2620.26
May 2621.93
May 2619.62
May 2619.32
May 2620.27
May 2619.87
Apr 2618.9
Apr 2619.62
Apr 2616.42
Apr 2620.84
Mar 2619.28
Mar 2621.24
Mar 2621.49
Mar 2622.77
Feb 2619.86
Feb 2619.59
Feb 2621.79
Feb 2623.17
Jan 2624.06
Jan 2625.95
Jan 2627.8
Jan 2630.19
Jan 2629.17
Dec 2530.11
Dec 2531.42
Dec 2530.78
Dec 2529.89
Nov 2527.57
Nov 2527.6
Nov 2530.17
Nov 2522.98
Oct 2525.46
Oct 2527.84
Oct 2527.13
Oct 2528.5
Oct 2527.78
Sep 2527.8
Sep 2526.28
Sep 2525.07
Sep 2524.79
Aug 2524.47
Aug 2524.04
Aug 2523.28
Aug 2523.59
Aug 2523.81
Jul 2524.89
Jul 2525
Jul 2525.36
Jul 2526.86
Jun 2527.52
Jun 2526.89
Jun 2527.43
Jun 2528.73
May 2528.99
May 2529.91
May 2530.26
May 2535.01
May 2535.54
Apr 2534.66
Apr 2533.35
Apr 2533.92
Apr 2531.25
Mar 2534.34
Mar 2533.94
Mar 2534.62
Mar 2533.33
Feb 2535.2
Feb 2536.27
Feb 2538.88
Feb 2548.2
Jan 2545.6
Jan 2544.95
Jan 2543.21
Jan 2540.91
Jan 2541.92
Dec 2442.11
Dec 2442.72
Dec 2437.71
Dec 2440.5
Nov 2438.28
Nov 2437.4
Nov 2433.57
Nov 2435.3
Nov 2437.79
Oct 2437.3
Oct 2437.01
Price to Book
020406080med 10.12Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CLBT Price to Book by quarter
PeriodPrice to Book
Sep 265.17
Sep 265.27
Aug 265.52
Aug 265.08
Aug 265.13
Aug 267.73
Jul 267.12
Jul 266.86
Jul 267.45
Jul 267.7
Jul 267.56
Jun 266.64
Jun 266.19
Jun 266.2
Jun 266.67
May 267.65
May 266.84
May 266.74
May 267.07
May 266.93
Apr 266.59
Apr 266.84
Apr 265.73
Apr 267.27
Mar 266.72
Mar 267.41
Mar 267.5
Mar 267.95
Feb 266.93
Feb 266.83
Feb 267.6
Feb 267.9
Jan 268.21
Jan 268.85
Jan 269.48
Jan 2610.3
Jan 269.95
Dec 2510.27
Dec 2510.72
Dec 2510.5
Dec 2510.2
Nov 259.4
Nov 259.42
Nov 2510.29
Nov 259.06
Oct 2510.04
Oct 2510.98
Oct 2510.7
Oct 2511.24
Oct 2510.96
Sep 2510.96
Sep 2510.36
Sep 259.89
Sep 259.78
Aug 259.65
Aug 259.48
Aug 259.18
Aug 259.28
Aug 259.37
Jul 259.79
Jul 259.83
Jul 259.98
Jul 2510.57
Jun 2510.83
Jun 2510.58
Jun 2510.79
Jun 2511.3
May 2511.41
May 2511.77
May 2511.91
May 2513.77
May 2513.98
Apr 2513.63
Apr 2513.12
Apr 2513.34
Apr 2512.29
Mar 2513.51
Mar 2513.35
Mar 2512.77
Mar 2512.29
Feb 2512.98
Feb 2513.38
Feb 2514.34
Feb 2517.78
Jan 2516.82
Jan 2516.58
Jan 2515.94
Jan 2515.09
Jan 2515.46
Dec 2415.53
Dec 2415.76
Dec 2413.91
Dec 2414.94
Nov 2414.12
Nov 2413.8
Nov 2412.38
Nov 2413.02
May 2465.53
May 2462.8
May 2460.93
Cellebrite DI Ltd.
CLBT
Stockpicker

Video analysis: CLBT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CLBT

Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation

newsfilecorp.com · 10 Sep 2026

Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation

New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations

newsfilecorp.com · 8 Sep 2026

Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations

New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

Cellebrite DI (NASDAQ:CLBT) and Riskified (NYSE:RSKD) Head to Head Contrast

defenseworld.net · 8 Sep 2026

Cellebrite DI (NASDAQ:CLBT) and Riskified (NYSE:RSKD) Head to Head Contrast

Riskified (NYSE: RSKD - Get Free Report) and Cellebrite DI (NASDAQ: CLBT - Get Free Report) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Earnings and Valuation This table compares Riskified and Cellebrite

Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights

newsfilecorp.com · 4 Sep 2026

Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

Cellebrite Announces Upcoming Investor Events in September

prnewswire.com · 4 Sep 2026

Cellebrite Announces Upcoming Investor Events in September

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.

Cellebrite anuncia próximos eventos para inversores en septiembre

prnewswire.com · 4 Sep 2026

Cellebrite anuncia próximos eventos para inversores en septiembre

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público

Cellebrite annonce des événements destinés aux investisseurs en septembre

prnewswire.com · 4 Sep 2026

Cellebrite annonce des événements destinés aux investisseurs en septembre

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions d'enquête et de renseignement numériques alimentées par l'IA pour les secteurs

Cellebrite kündigt für September bevorstehende Investorenveranstaltungen an

prnewswire.com · 4 Sep 2026

Cellebrite kündigt für September bevorstehende Investorenveranstaltungen an

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.